Literature DB >> 23424563

4-[5-(4-Chloro-phen-yl)-3-methyl-1H-pyrazol-1-yl]benzene-sulfonamide.

Muhammad A Farrukh1, Shaaban K Mohamed, Maqsood Ahmed, Adel A Marzouk, Samir M El-Moghazy.   

Abstract

In the title compound, C(16)H(14)ClN(3)O(2)S, the dihedral angle between the benzene and pyrazole rings is 52.75 (2)°, while that between the pyrazole and 4-chloro-phenyl rings is 54.0 (3)°. The terminal sulfonamide group adopts an approximately tetra-hedral geometry about the S atom with a C-S-N angle of 108.33 (10)°. In the crystal, pairs of N-H⋯N hydrogen bonds lead to the formation of inversion dimers. These dimers are linked via a second pair of N-H⋯N hydrogen bonds and C-H⋯O interactions, forming a two-dimensional network lying parallel to the bc plane. The two-dimensional networks are linked via C-H⋯Cl interactions, forming a three-dimensional structure.

Entities:  

Year:  2013        PMID: 23424563      PMCID: PMC3569817          DOI: 10.1107/S1600536813002134

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the use of pyrazoles in metal-organic chemistry, see: Mukherjee (2000 ▶); Halcrow (2009 ▶). For the synthesis and pharmaceutical applications of pyrazole compounds, see, for example: Ranatunge et al. (2004 ▶); Szabo et al. (2008 ▶); Bekhit & Abdel-Aziem (2004 ▶); Bekhit et al. (2006 ▶); Rostom et al. (2003 ▶); Gökhan-Kelekçi et al. (2007 ▶); Lin et al. (2007 ▶); El-Moghazy et al. (2012 ▶); Sakya et al. (2008 ▶); Shen et al. (2004 ▶).

Experimental

Crystal data

C16H14ClN3O2S M = 347.81 Monoclinic, a = 15.878 (5) Å b = 8.209 (5) Å c = 12.953 (5) Å β = 91.016 (5)° V = 1688.1 (13) Å3 Z = 4 Mo Kα radiation μ = 0.36 mm−1 T = 296 K 0.33 × 0.32 × 0.18 mm

Data collection

Bruker Kappa APEXII CCD diffractometer Absorption correction: analytical (SADABS; Bruker, 2009 ▶) T min = 0.890, T max = 0.938 17257 measured reflections 3462 independent reflections 2594 reflections with I > 2σ(I) R int = 0.030

Refinement

R[F 2 > 2σ(F 2)] = 0.041 wR(F 2) = 0.115 S = 1.03 3462 reflections 217 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.34 e Å−3 Δρmin = −0.33 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SIR92 (Altomare et al., 1993 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 (Farrugia, 2012 ▶) and Mercury (Macrae et al., 2008 ▶); software used to prepare material for publication: publCIF (Westrip, 2010 ▶). Click here for additional data file. Crystal structure: contains datablock(s) I, global_Publ_Block. DOI: 10.1107/S1600536813002134/sj5296sup1.cif Click here for additional data file. Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536813002134/sj5296Isup2.hkl Click here for additional data file. Supplementary material file. DOI: 10.1107/S1600536813002134/sj5296Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C16H14ClN3O2SF(000) = 720
Mr = 347.81Dx = 1.369 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 133 reflections
a = 15.878 (5) Åθ = 2.7–26.0°
b = 8.209 (5) ŵ = 0.36 mm1
c = 12.953 (5) ÅT = 296 K
β = 91.016 (5)°Block, colourless
V = 1688.1 (13) Å30.33 × 0.32 × 0.18 mm
Z = 4
Bruker Kappa APEXII CCD diffractometer3462 independent reflections
Radiation source: fine-focus sealed tube2594 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.030
ω and φ scansθmax = 26.4°, θmin = 2.8°
Absorption correction: analytical (SADABS; Bruker, 2009)h = −19→19
Tmin = 0.890, Tmax = 0.938k = −10→10
17257 measured reflectionsl = −16→16
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.041Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.115H atoms treated by a mixture of independent and constrained refinement
S = 1.03w = 1/[σ2(Fo2) + (0.0506P)2 + 0.8701P] where P = (Fo2 + 2Fc2)/3
3462 reflections(Δ/σ)max < 0.001
217 parametersΔρmax = 0.34 e Å3
0 restraintsΔρmin = −0.33 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
S10.62888 (4)0.52544 (6)−0.26035 (4)0.03590 (16)
Cl11.07396 (5)0.23198 (14)0.03417 (10)0.1065 (4)
O10.70283 (10)0.5918 (2)−0.30442 (11)0.0545 (5)
N10.55446 (14)0.6528 (2)−0.27978 (14)0.0381 (4)
N30.62419 (11)0.5109 (2)0.25734 (12)0.0338 (4)
O20.59721 (12)0.37105 (18)−0.29389 (11)0.0551 (5)
N20.68811 (10)0.4740 (2)0.19252 (12)0.0327 (4)
C10.64780 (13)0.5101 (2)−0.12544 (14)0.0316 (4)
C30.72856 (14)0.5768 (3)0.02534 (16)0.0434 (5)
H30.77380.63060.05670.052*
C60.59263 (14)0.4216 (3)−0.06641 (15)0.0383 (5)
H60.54650.3703−0.09750.046*
C40.67440 (13)0.4873 (2)0.08368 (14)0.0311 (4)
C110.83783 (14)0.3838 (3)0.19450 (17)0.0467 (6)
C20.71592 (14)0.5872 (3)−0.08065 (16)0.0429 (5)
H20.75320.6457−0.12100.051*
C50.60608 (13)0.4095 (3)0.03862 (15)0.0372 (5)
H50.56940.34930.07880.045*
C90.65766 (15)0.4978 (3)0.35195 (16)0.0403 (5)
C100.60555 (18)0.5323 (3)0.44406 (17)0.0550 (7)
H10A0.55070.56870.42190.082*
H10B0.63220.61560.48510.082*
H10C0.60020.43490.48440.082*
C70.76017 (14)0.4366 (3)0.24501 (16)0.0415 (5)
C160.83766 (17)0.2553 (4)0.1266 (3)0.0688 (8)
H160.78770.19940.11300.083*
C80.74152 (15)0.4516 (3)0.34751 (17)0.0506 (6)
H80.77810.43410.40330.061*
C140.98314 (17)0.2900 (4)0.0978 (3)0.0676 (8)
C120.91258 (18)0.4628 (4)0.2135 (3)0.0808 (10)
H120.91430.54920.25990.097*
C150.91033 (19)0.2080 (4)0.0784 (3)0.0800 (10)
H150.90950.12040.03290.096*
C130.98526 (19)0.4160 (5)0.1648 (3)0.0943 (12)
H131.03550.47100.17810.113*
H2N10.5670 (16)0.747 (3)−0.266 (2)0.050 (8)*
H1N10.5061 (18)0.620 (4)−0.265 (2)0.061 (9)*
U11U22U33U12U13U23
S10.0498 (3)0.0367 (3)0.0213 (2)0.0057 (2)0.0010 (2)−0.0004 (2)
Cl10.0537 (5)0.1252 (8)0.1417 (9)0.0173 (5)0.0359 (5)0.0154 (7)
O10.0500 (10)0.0833 (12)0.0304 (8)0.0055 (9)0.0090 (7)0.0095 (8)
N10.0445 (12)0.0344 (10)0.0352 (10)−0.0008 (9)−0.0052 (8)0.0011 (8)
N30.0408 (10)0.0353 (9)0.0254 (8)0.0006 (7)0.0019 (7)0.0009 (7)
O20.0967 (14)0.0358 (8)0.0324 (8)0.0054 (9)−0.0079 (8)−0.0078 (7)
N20.0359 (9)0.0379 (9)0.0241 (8)−0.0004 (7)−0.0012 (7)0.0010 (7)
C10.0395 (11)0.0323 (10)0.0229 (9)0.0057 (9)0.0007 (8)0.0003 (8)
C30.0409 (12)0.0568 (14)0.0322 (11)−0.0150 (10)−0.0038 (9)0.0033 (10)
C60.0434 (12)0.0406 (11)0.0305 (10)−0.0086 (10)−0.0058 (9)0.0012 (9)
C40.0369 (11)0.0330 (10)0.0235 (9)0.0028 (8)−0.0006 (8)0.0011 (8)
C110.0370 (12)0.0625 (15)0.0405 (12)0.0009 (11)−0.0062 (10)0.0068 (11)
C20.0423 (12)0.0556 (14)0.0309 (11)−0.0108 (11)0.0035 (9)0.0075 (10)
C50.0419 (12)0.0399 (11)0.0297 (10)−0.0081 (9)0.0004 (9)0.0046 (9)
C90.0529 (14)0.0426 (12)0.0255 (10)−0.0081 (10)−0.0005 (9)0.0010 (9)
C100.0704 (17)0.0659 (16)0.0290 (11)−0.0104 (13)0.0082 (11)−0.0044 (11)
C70.0388 (12)0.0524 (13)0.0331 (11)−0.0018 (10)−0.0069 (9)0.0033 (10)
C160.0398 (14)0.078 (2)0.089 (2)−0.0038 (13)0.0061 (14)−0.0206 (17)
C80.0510 (14)0.0721 (17)0.0284 (11)−0.0033 (12)−0.0110 (10)0.0048 (11)
C140.0388 (14)0.083 (2)0.081 (2)0.0101 (14)0.0075 (14)0.0159 (17)
C120.0460 (16)0.102 (2)0.095 (2)−0.0116 (16)−0.0052 (16)−0.027 (2)
C150.0517 (18)0.088 (2)0.100 (3)0.0071 (16)0.0087 (17)−0.0284 (19)
C130.0375 (16)0.111 (3)0.134 (3)−0.0149 (17)0.0036 (18)−0.018 (3)
S1—O11.4229 (17)C11—C161.373 (4)
S1—O21.4284 (18)C11—C71.471 (3)
S1—N11.594 (2)C2—H20.9300
S1—C11.772 (2)C5—H50.9300
Cl1—C141.740 (3)C9—C81.387 (3)
N1—H2N10.82 (3)C9—C101.491 (3)
N1—H1N10.84 (3)C10—H10A0.9600
N3—C91.331 (3)C10—H10B0.9600
N3—N21.363 (2)C10—H10C0.9600
N2—C71.356 (3)C7—C81.371 (3)
N2—C41.427 (2)C16—C151.378 (4)
C1—C21.373 (3)C16—H160.9300
C1—C61.380 (3)C8—H80.9300
C3—C41.369 (3)C14—C131.351 (5)
C3—C21.387 (3)C14—C151.357 (4)
C3—H30.9300C12—C131.379 (4)
C6—C51.377 (3)C12—H120.9300
C6—H60.9300C15—H150.9300
C4—C51.380 (3)C13—H130.9300
C11—C121.371 (4)
O1—S1—O2120.40 (11)C6—C5—H5120.3
O1—S1—N1107.47 (12)C4—C5—H5120.3
O2—S1—N1106.13 (12)N3—C9—C8110.59 (19)
O1—S1—C1107.23 (10)N3—C9—C10120.2 (2)
O2—S1—C1106.82 (9)C8—C9—C10129.2 (2)
N1—S1—C1108.33 (10)C9—C10—H10A109.5
S1—N1—H2N1114.2 (18)C9—C10—H10B109.5
S1—N1—H1N1116 (2)H10A—C10—H10B109.5
H2N1—N1—H1N1118 (3)C9—C10—H10C109.5
C9—N3—N2105.06 (17)H10A—C10—H10C109.5
C7—N2—N3111.87 (16)H10B—C10—H10C109.5
C7—N2—C4128.71 (18)N2—C7—C8105.7 (2)
N3—N2—C4119.31 (16)N2—C7—C11123.38 (19)
C2—C1—C6120.78 (18)C8—C7—C11130.8 (2)
C2—C1—S1120.16 (16)C11—C16—C15121.0 (3)
C6—C1—S1119.06 (15)C11—C16—H16119.5
C4—C3—C2119.88 (19)C15—C16—H16119.5
C4—C3—H3120.1C7—C8—C9106.77 (19)
C2—C3—H3120.1C7—C8—H8126.6
C5—C6—C1119.78 (19)C9—C8—H8126.6
C5—C6—H6120.1C13—C14—C15120.7 (3)
C1—C6—H6120.1C13—C14—Cl1120.2 (2)
C3—C4—C5120.80 (18)C15—C14—Cl1119.2 (3)
C3—C4—N2120.02 (18)C11—C12—C13121.0 (3)
C5—C4—N2119.18 (18)C11—C12—H12119.5
C12—C11—C16118.0 (3)C13—C12—H12119.5
C12—C11—C7120.7 (2)C14—C15—C16119.6 (3)
C16—C11—C7121.3 (2)C14—C15—H15120.2
C1—C2—C3119.3 (2)C16—C15—H15120.2
C1—C2—H2120.4C14—C13—C12119.7 (3)
C3—C2—H2120.4C14—C13—H13120.2
C6—C5—C4119.44 (19)C12—C13—H13120.2
C9—N3—N2—C70.7 (2)N2—N3—C9—C10179.11 (19)
C9—N3—N2—C4−175.84 (17)N3—N2—C7—C8−0.5 (2)
O1—S1—C1—C212.9 (2)C4—N2—C7—C8175.7 (2)
O2—S1—C1—C2143.19 (18)N3—N2—C7—C11176.7 (2)
N1—S1—C1—C2−102.9 (2)C4—N2—C7—C11−7.2 (3)
O1—S1—C1—C6−167.96 (17)C12—C11—C7—N2126.0 (3)
O2—S1—C1—C6−37.6 (2)C16—C11—C7—N2−53.5 (4)
N1—S1—C1—C676.33 (19)C12—C11—C7—C8−57.6 (4)
C2—C1—C6—C5−0.3 (3)C16—C11—C7—C8122.9 (3)
S1—C1—C6—C5−179.52 (16)C12—C11—C16—C15−0.5 (5)
C2—C3—C4—C5−1.3 (3)C7—C11—C16—C15179.0 (3)
C2—C3—C4—N2178.9 (2)N2—C7—C8—C90.1 (3)
C7—N2—C4—C3−48.5 (3)C11—C7—C8—C9−176.8 (2)
N3—N2—C4—C3127.4 (2)N3—C9—C8—C70.4 (3)
C7—N2—C4—C5131.7 (2)C10—C9—C8—C7−179.3 (2)
N3—N2—C4—C5−52.5 (3)C16—C11—C12—C130.8 (5)
C6—C1—C2—C3−0.7 (3)C7—C11—C12—C13−178.7 (3)
S1—C1—C2—C3178.52 (18)C13—C14—C15—C160.9 (6)
C4—C3—C2—C11.5 (4)Cl1—C14—C15—C16−178.5 (3)
C1—C6—C5—C40.5 (3)C11—C16—C15—C14−0.3 (5)
C3—C4—C5—C60.3 (3)C15—C14—C13—C12−0.5 (6)
N2—C4—C5—C6−179.87 (19)Cl1—C14—C13—C12178.9 (3)
N2—N3—C9—C8−0.6 (2)C11—C12—C13—C14−0.3 (6)
D—H···AD—HH···AD···AD—H···A
N1—H2N1···N3i0.82 (2)2.20 (2)3.010 (3)169 (2)
N1—H1N1···N3ii0.84 (3)2.33 (3)3.157 (3)167 (3)
C5—H5···O2iii0.932.483.169131
C3—H3···Cl1iv0.932.933.602130
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
N1—H2N1⋯N3i 0.82 (2)2.20 (2)3.010 (3)169 (2)
N1—H1N1⋯N3ii 0.84 (3)2.33 (3)3.157 (3)167 (3)
C5—H5⋯O2iii 0.932.483.169131
C3—H3⋯Cl1iv 0.932.933.602130

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) .

  10 in total

1.  Comparative structure-activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition.

Authors:  Subas M Sakya; Andrei Shavnya; Hengmiao Cheng; Chao Li; Bryson Rast; Jin Li; David A Koss; Burton H Jaynes; Donald W Mann; Carol F Petras; Scott B Seibel; Michelle L Haven; Michael P Lynch
Journal:  Bioorg Med Chem Lett       Date:  2008-01-07       Impact factor: 2.823

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors.

Authors:  Ronghui Lin; George Chiu; Yang Yu; Peter J Connolly; Shengjian Li; Yanhua Lu; Mary Adams; Angel R Fuentes-Pesquera; Stuart L Emanuel; Lee M Greenberger
Journal:  Bioorg Med Chem Lett       Date:  2007-06-06       Impact factor: 2.823

4.  Pyrazoles and pyrazolides-flexible synthons in self-assembly.

Authors:  Malcolm A Halcrow
Journal:  Dalton Trans       Date:  2009-01-23       Impact factor: 4.390

5.  New celecoxib derivatives as anti-inflammatory agents.

Authors:  György Szabó; János Fischer; Agnes Kis-Varga; Klára Gyires
Journal:  J Med Chem       Date:  2007-12-12       Impact factor: 7.446

6.  Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents.

Authors:  Adnan A Bekhit; Tarek Abdel-Aziem
Journal:  Bioorg Med Chem       Date:  2004-04-15       Impact factor: 3.641

7.  Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains.

Authors:  Dong-Ming Shen; Min Shu; Sander G Mills; Kevin T Chapman; Lorraine Malkowitz; Martin S Springer; Sandra L Gould; Julie A DeMartino; Salvatore J Siciliano; Gloria Y Kwei; Anthony Carella; Gwen Carver; Karen Holmes; William A Schleif; Renee Danzeisen; Daria Hazuda; Joseph Kessler; Janet Lineberger; Michael D Miller; Emilio A Emini
Journal:  Bioorg Med Chem Lett       Date:  2004-02-23       Impact factor: 2.823

8.  A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.

Authors:  Nesrin Gökhan-Kelekçi; Samiye Yabanoğlu; Esra Küpeli; Umut Salgin; Ozen Ozgen; Gülberk Uçar; Erdem Yeşilada; Engin Kendi; Akgül Yeşilada; A Altan Bilgin
Journal:  Bioorg Med Chem       Date:  2007-06-08       Impact factor: 3.641

9.  Polysubstituted pyrazoles, part 5. Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HCV agents.

Authors:  Sherif A F Rostom; Manal A Shalaby; Maha A El-Demellawy
Journal:  Eur J Med Chem       Date:  2003 Nov-Dec       Impact factor: 6.514

10.  3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.

Authors:  Ramani R Ranatunge; Richard A Earl; David S Garvey; David R Janero; L Gordon Letts; Allison M Martino; Madhavi G Murty; Stewart K Richardson; David J Schwalb; Delano V Young; Irina S Zemtseva
Journal:  Bioorg Med Chem Lett       Date:  2004-12-20       Impact factor: 2.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.